Heterocyclic compounds
US6713485B2 · kind B2 · utility
68Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2002 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Mar 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted heteroaromatic compounds, methods for their preparation, pharmaceutical compositions containing them and their use in medicine. Specifically, the invention relates to quinazoline derivatives useful in treating disorders mediated by protein tyrosine kinase activity, in particular erbB-2 and/or EGFR activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.